ARDS
Aridis Pharmaceuticals, Inc.
Set alert
0.00 USD 0.00 0.00%
0.00145 Day range 0.00145
0.0001 52-week range 0.0031
- YTD
- -86.67%
- 1 year
- -86.21%
- Open
- 0.00145
- Prev close
- 0.0002
- Mkt cap
- 8.91K
- Vol
- 10
- Avg vol
- 4.74K
- EPS
- -0.32
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.00145
- High
- 0.00145
- Forward P/E
- 1.35
- Beta
- 0.78
- Short ratio
- 0.22
- Inst. own
- 11.60%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Dec 23, 2024
- 50-d avg
- 0.2338
- 200-d avg
- 0.63715
- 1y target
- 10.00
Financial health
Altman Z-Score
-40.63 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -0.7×
FY 2016 5y median -1.3× FY 2022
P/S 0.0×
FY 2016 5y median 12.7× FY 2022
P/B -0.9×
FY 2016 5y median -0.9× FY 2022
P/FCF -0.8×
FY 2016 5y median -1.4× FY 2022
EV/EBITDA -0.8×
FY 2016 5y median -0.6× FY 2022
EV/Sales 0.0×
FY 2016 5y median 3.9× FY 2022
FCF Yield -131.8%
FY 2016 5y median -71.5% FY 2022
Profitability
Gross Margin 0.0%
FY 2016 5y median 100.0% FY 2022
Operating Margin 0.0%
FY 2016 5y median -874.8% FY 2022
Net Margin 0.0%
FY 2016 5y median -801.8% FY 2022
ROE 126.9%
FY 2016 5y median 126.9% FY 2022
ROIC 172.7%
FY 2016 5y median 172.7% FY 2022
ROA -209.2%
FY 2016 5y median -147.7% FY 2022
Growth (YoY)
Revenue 0.0%
FY 2016 FY 2022
Operating Income 31.4%
FY 2016 FY 2022
EPS (diluted) 52.3%
FY 2016 FY 2022
Free Cash Flow -24.5%
FY 2016 FY 2022
Financial Health
Current Ratio 0.3×
FY 2016 5y median 0.8× FY 2022
Quick Ratio 0.3×
FY 2016 5y median 0.8× FY 2022
Debt / Equity -0.3×
FY 2016 5y median -0.1× FY 2022
Net Debt / EBITDA -0.0×
FY 2016 5y median 0.3× FY 2022
Interest Coverage -79.3×
FY 2016 5y median 0.0× FY 2022
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2022
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2022
Annual · latest fiscal year ends 2022-12-31